Safety and Immunogenicity of XBB.1.5-Containing mRNA VaccinesSpyros Chalkias, Rituparna Das, Adam Brosz et al.|medRxiv|2023Cited by 79
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim resultsSpyros Chalkias, Rituparna Das, Jordan L. Whatley et al.|Nature Medicine|2023Cited by 77